Saruparib

Interviews and expert commentary tagged “Saruparib” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Timothy Yap MD PhD MBBS: Selective PARP1 Inhibitor Saruparib Clinical Promise in Solid Tumors with Homologous Recombination Repair Deficiency
Audio Journal of Oncology

Timothy Yap MD PhD MBBS: Selective PARP1 Inhibitor Saruparib Clinical Promise in Solid Tumors with Homologous Recombination Repair Deficiency

Timothy Yap MD PhD MBBS selective PARP inhibitor promise in breast, ovarian, pancreatic, prostate tumors.

22 September 2025
18:45
← Browse all episodes